Find the latest regulatory and safety information on COVID-19 treatments in Australia.
We rigorously assess all COVID-19 treatments for safety, quality and effectiveness before they can be registered for use in Australia.
This page will be regularly updated to keep consumers, health professionals and sponsors informed of the latest regulatory developments.
The TGA continues to monitor the safety of medicines after they are registered in Australia so that we can detect and respond to any safety concerns. If you think you may be experiencing a significant side effect (also known as an adverse event) to a COVID-19 treatment, you should seek advice from your doctor. Further information about adverse events can be found on the Reporting adverse events web page.
If you think you have experienced a side effect from a COVID-19 treatment you can report it via:
Telephone 1300 134 237 (8am-8pm seven days a week) – the NPS MedicineWise Adverse Medicine Events line
Online form TGA adverse event reporting
If you have an enquiry about the COVID-19 treatment regulatory process, use the following contact details:
Email info@tga.gov.au
Telephone 1800 020 653
If you have a general enquiry about COVID-19 or the vaccine roll-out, contact the National Coronavirus Helpline on:
Telephone 1800 020 080 (available 24 hours a day, seven days a week)